|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.24 USD | -2.27% |
|
+4.12% | -1.90% |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
| 06-09 | Zai Lab Says China Approves Tivdak for Cervical Cancer Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZAI LAB LIMITED | Biopharmaceuticals | -1.93% | +4.12% | -1.90% | -59.78% | -89.82% | 1.98B |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















